Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 The clinical characteristics of the blood culture positive patients for Stenotrophomonas maltophilia

From: An evaluation of a Stenotrophomonas maltophilia outbreak due to commercial arterial blood gas collection kit

 

n (%)

 

Age Children (≤ 18 years)

Adult (> 18 years)

(median year, average range)

16 (30.7%)

36 (69.2%)

39 (1 months − 87 years)

 

Gender (Female)

30 (57%)

 

ICU

32 (61.5%)

 

Baseline diseases

 

Hypertension

Malignancy

Leukemia

Diabetes mellitus

Hearth diseases

Chronic renal failure

Acute renal failure

Liver disease

COVID 19

Pulmonary disease

Sepsis

Acute gastroenteritis

Intracranial abscess

9 (17%)

9 (17%)

3 (5.7%)

8 (15.3%)

13 (25%)

9 (17%)

2 (3.8%)

1 (1.9%)

10 (19.2%)

10 (19.2%)

2 (3.8%)

1 (1.9%)

1 (1.9%)

 

Catheter

46 ( 88.4%)

 

Central venous catheter

43 (83% )

 

Previous antibiotic usage

40 (76.9%)

 

Cephalosporins

Carbapenem

Piperacillin-tazobactam

Sulbactam-ampisilin

Aminoglycosides

Glycopeptides

6 (11.5%)

30 (57.6%)

5 (9.6%)

2 (3.8%)

2 (3.8%)

16 (30.7%)

 

Bronchoscopy

5 (9.6%)

 

Total parenteral nutrition

10 (19.2%)

 

Operation

21 (40.38%)

 

Interventional radiology

2 (3.8%)